Boston University's National Emerging Infectious Disease Laboratories (NEIDL) received final approval from the Boston Public Health Commission to conduct biosafety level 4 (BSL-4) research, clearing the final hurdle to begin work on some of the world's most lethal pathogens, such as Ebola and Marburg virus, BU Today, the campus newspaper, reported.
The Saudi Arabian Ministry of Health (MOH) reported a new case of MERS-CoV in Sakaka, a city in the northwestern corner of the country.
A 64-year-old Saudi man is in stable condition after presenting with symptoms of MERS-CoV (Middle East respiratory syndrome coronavirus) infection. His source of infection is listed as "primary," meaning it's unlikely he contracted the virus from another person.
Trials of both an inactivated and a DNA vaccine showed good safety and immune response data.
In the past month the Pan American Health Organization (PAHO) has reported 1,106 new chikungunya infections, bringing the yearly total to 184,636 confirmed, suspected, and imported cases.
Japan-based Takeda announces the launch of a phase 1 trial of its Zika vaccine.
Experiments in guinea pigs to explore possible routes of Zika transmission found that infected animals can pass the virus to healthy cagemates, perhaps through tears or saliva, researchers from China reported today in Nature Communications.
The Saudi Arabian Ministry of Health (MOH) reported a new case of MERS-CoV over the weekend.
The study of people in Salvador, Brazil, shows infection rates exceeding 60% in many populations.
The study highlights ADE, when previous virus exposure enhances disease response.
In the past, the city has experienced outbreaks of dengue, Zika, and chikungunya that were spread by Aedes aegypti mosquitoes.
